Small-cell carcinoma of the ovary hypercalcaemic type shows a wild-type immunohistochemical staining pattern of p53
Felix K F Kommoss
Institute of Pathology, University Hospital Heidelberg, Heidelberg
Search for more papers by this authorDietmar Schmidt
Wissenschaftspark Trier, MVZ für Histologie, Zytologie und molekulare Diagnostik GmbH, Trier
Search for more papers by this authorFriedrich Kommoss
Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany
Search for more papers by this authorCorresponding Author
Basile Tessier-Cloutier
Department of Pathology, McGill University, Montreal, QC
Division of Pathology, McGill University Health Centre, Montreal, QC, Canada
Address for correspondence: B. Tessier-Cloutier, Department of Pathology, McGill University, Gynecologic Pathologist, Division of Pathology, McGill University Health Centre, 1001 Decarie Boulevard, Room E04.4131, Montreal, QC H4A 3J1, Canada. e-mail: [email protected]Search for more papers by this authorFelix K F Kommoss
Institute of Pathology, University Hospital Heidelberg, Heidelberg
Search for more papers by this authorDietmar Schmidt
Wissenschaftspark Trier, MVZ für Histologie, Zytologie und molekulare Diagnostik GmbH, Trier
Search for more papers by this authorFriedrich Kommoss
Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany
Search for more papers by this authorCorresponding Author
Basile Tessier-Cloutier
Department of Pathology, McGill University, Montreal, QC
Division of Pathology, McGill University Health Centre, Montreal, QC, Canada
Address for correspondence: B. Tessier-Cloutier, Department of Pathology, McGill University, Gynecologic Pathologist, Division of Pathology, McGill University Health Centre, 1001 Decarie Boulevard, Room E04.4131, Montreal, QC H4A 3J1, Canada. e-mail: [email protected]Search for more papers by this authorConflicts of interest
The authors declare no competing interests.
References
- 1 Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474; 609–615.
- 2Kobel M, Piskorz AM, Lee S et al. Optimized p53 immunohistochemistry is an accurate predictor of tp53 mutation in ovarian carcinoma. J. Pathol. Clin. Res. 2016; 2; 247–258.
- 3Kobel M, Rahimi K, Rambau PF et al. An immunohistochemical algorithm for ovarian carcinoma typing. Int. J. Gynecol. Pathol. 2016; 35; 430–441.
- 4McCluggage WG, Oliva E, Connolly LE, McBride HA, Young RH. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int. J. Gynecol. Pathol. 2004; 23; 330–336.
- 5Seidman JD. Small cell carcinoma of the ovary of the hypercalcemic type: P53 protein accumulation and clinicopathologic features. Gynecol. Oncol. 1995; 59; 283–287.
- 6Fahiminiya S, Witkowski L, Nadaf J et al. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor. Oncotarget 2016; 7; 1732–1740.
- 7Kommoss FK, Tessier-Cloutier B, Witkowski L et al. Cellular context determines DNA methylation profiles in swi/snf-deficient cancers of the gynecologic tract. J. Pathol. 2022; 257; 140–145.
- 8Gamwell LF, Gambaro K, Merziotis M et al. Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics. Orphanet J. Rare Dis. 2013; 8; 33.
- 9Coatham M, Li X, Karnezis AN et al. Concurrent arid1a and arid1b inactivation in endometrial and ovarian dedifferentiated carcinomas. Mod. Pathol. 2016; 29; 1586–1593.
- 10Tessier-Cloutier B, Köbel M, Momeni-Boroujeni A et al. Polymerase-ɛ exonuclease domain mutations predict excellent outcome among swi/snf-deficient undifferentiated and dedifferentiated endometrial carcinomas – 34(th) european congress of pathology – abstracts. Virchows Arch. 2022; 481; 1–364.
